RBC Europe’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
RBC Europe's MDT Position: Q2 2022 in Review
RBC Europe reduced its Medtronic (MDT) stake by 0.36% in Q2 2022, selling an estimated $13K and leaving 35,399 shares worth $3.18M. The position accounts for 0.15% of the portfolio, ranked #61.
RBC Europe first reported a position in MDT in Q3 2017 and has held it in 20 quarters since. The position peaked at $4.65M in Q3 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.
- RBC Europe held 35,399 shares of Medtronic worth $3.18M as of Q2 2022.
- RBC Europe sold 128 Medtronic shares in Q2 2022, an estimated $13K.
- Medtronic made up 0.15% of RBC Europe's portfolio in Q2 2022, its #61 holding.
- RBC Europe first reported a position in Medtronic in Q3 2017 and has held it in 20 quarters since.
- RBC Europe's Medtronic position peaked at $4.65M in Q3 2021.
- 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.
Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.